Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions?

World Journal of Biological Psychiatry

Volumn 17, Issue 8, 2016, Pages 634-640

  Regen, F ^a   Le Bret, N ^a   Hildebrand, M ^a   Herzog, I ^a   Heuser, I ^a   Hellmann Regen, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cytochrome p450 metabolism; major depression; minocycline; neuroprotection; retinoic acid

Indexed keywords

MINOCYCLINE; RETINOIC ACID; CYTOCHROME P450;

ANIMAL CELL; ARTICLE; BIODEGRADATION; BRAIN METABOLISM; BRAIN SYNAPTOSOME; CATABOLISM; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL CULTURE; NEUROBLASTOMA CELL LINE; NONHUMAN; PLEIOTROPY; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BRAIN; DRUG EFFECTS; MALE; METABOLISM; NERVE CELL; NEUROBLASTOMA; REGRESSION ANALYSIS; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; BRAIN; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MALE; MINOCYCLINE; NEUROBLASTOMA; NEURONS; RATS; RATS, WISTAR; REGRESSION ANALYSIS; TRETINOIN;

EID: 84994508076     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2015.1036116     Document Type: Article

References (50)

1. S.Abu-Abed, P.Dolle, D.Metzger, B.Beckett, P.Chambon, M.Petkovich. 2001. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 15:226–240.
2. J.Aoto, C.I.Nam, M.M.Poon, P.Ting, L.Chen. 2008. Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity. Neuron 60:308–320.
3. J.D.Bremner, K.D.Shearer, P.J.McCaffery. 2012. Retinoic acid and affective disorders:the evidence for an association. J Clin Psychiatry 73:37–50.
4. S.Casha, D.Zygun, M.D.McGowan, I.Bains, V.W.Yong, R.J.Hurlbert. 2012. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 135:1224–1236.
5. A.M.Chiu, W.L.Chuenkongkaew, W.T.Cornblath, J.D.Trobe, K.B.Digre, S.A.Dotan,. 1998. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 126:116–121.
6. J.P.Corcoran, P.L.So, M.Maden. 2004. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 20:896–902.
7. P.E.Cramer, J.R.Cirrito, D.W.Wesson, C.Y.Lee, J.C.Karlo, A.E.Zinn,. 2012. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503–1506.
8. O.M.Dean, J.Data-Franco, F.Giorlando, M.Berk. 2012. Minocycline:therapeutic potential in psychiatry. CNS Drugs 26:391–401.
9. S.T.Dheen, Y.Jun, Z.Yan, S.S.Tay, E.A.Ling. 2005. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 50:21–31.
10. Y.Ding, A.Qiao, Z.Wang, J.S.Goodwin, E.S.Lee, M.L.Block,. 2008. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 28:11622–11634.
11. K.S.Dixon, A.Hassoun. 2010. Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole. J Am Pharm Assoc (2003) 50:742–744.
12. D.I.Friedman. 2005. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 6:29–37.
13. Y.He, S.Appel, W.D.Le. 2001. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909:187–193.
14. J.Hellmann-Regen, K.Gertz, R.Uhlemann, M.Colla, M.Endres, G.Kronenberg. 2012. Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells. Eur Arch Psychiatry Clin Neurosci 262:697–704.
15. J.Hellmann-Regen, I.Herzog, N.Fischer, I.Heuser, F.Regen. 2014. Do tetracyclines and erythromycin exert anti-acne effects by inhibition of P450-mediated degradation of retinoic acid? Exp Dermatol 23:290–293.
16. J.Hellmann-Regen, I.Heuser, F.Regen. 2013a. UV-A emission from fluorescent energy-saving light bulbs alters local retinoic acid homeostasis. Photochem Photobiol Sci 12:2177–2185.
17. J.Hellmann-Regen, G.Kronenberg, R.Uhlemann, D.Freyer, M.Endres, K.Gertz. 2013b. Accelerated degradation of retinoic acid by activated microglia. J Neuroimmunol 256:1–6.
18. J.Hellmann-Regen, G.Kronenberg, R.Uhlemann, D.Freyer, M.Endres, K.Gertz. 2013c. Accelerated degradation of retinoic acid by activated microglia. J Neuroimmunol 256:1–6.
19. J.Hellmann, R.Juttner, C.Roth, M.Bajbouj, I.Kirste, I.Heuser,. 2011. Repetitive magnetic stimulation of human-derived neuron-like cells activates cAMP-CREB pathway. Eur Arch Psychiatry Clin Neurosci 262:87–91.
20. J.Hellmann, H.Rommelspacher, E.Muhlbauer, C.Wernicke. 2010. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev Neurosci 32:33–46.
21. H.Katsuki, E.Kurimoto, S.Takemori, Y.Kurauchi, A.Hisatsune, Y.Isohama,. 2009. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. J Neurochem 110:707–718.
22. R.G.Kelly, L.A.Kanegis. 1967. Metabolism and tissue distribution of radioisotopically labelled minocycline. Toxicol Appl Pharmacol 11:171–183.
23. J.H.Kim, K.S.Yu, J.H.Jeong, N.S.Lee, J.H.Lee, Y.G.Jeong,. 2013. All-trans-retinoic acid rescues neurons after global ischemia by attenuating neuroinflammatory reactions. Neurochem Res 38:2604–2615.
24. Y.Levkovitz, S.Mendlovich, S.Riwkes, Y.Braw, H.Levkovitch-Verbin, G.Gal,. 2010. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71:138–149.
25. M.Maden. 2007. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8:755–765.
26. P.McCaffery, J.Zhang, J.E.Crandall. 2006. Retinoic acid signaling and function in the adult hippocampus. J Neurobiol 66:780–791.
27. P.J.McCaffery, J.Adams, M.Maden, E.Rosa-Molinar. 2003. Too much of a good thing:retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 18:457–472.
28. L.C.McSorley, A.K.Daly. 2000. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem Pharmacol 60:517–526.
29. B.Melnik, U.Bros, G.Plewig. 1987. Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment. Dermatologica 175(Suppl 1):158–68.
30. B.C.Melnik. 2014. The P450 system and mTORC1 signalling in acne. Exp Dermatol 23:318–319.
31. B.C.Melnik, G.Schmitz. 2013. Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1? Exp Dermatol 22:502–504.
32. J.Mey, D.J.Morassutti, G.Brook, R.H.Liu, Y.P.Zhang, G.Koopmans,. 2005. Retinoic acid synthesis by a population of NG2-positive cells in the injured spinal cord. Eur J Neurosci 21:1555–1568.
33. T.Miyaoka, R.Wake, M.Furuya, K.Liaury, M.Ieda, K.Kawakami,. 2012. Minocycline as adjunctive therapy for patients with unipolar psychotic depression:an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 37:222–226.
34. M.Molina-Hernandez, N.P.Tellez-Alcantara, J.Perez-Garcia, J.I.Olivera-Lopez, M.T.Jaramillo-Jaimes. 2008. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 32:380–386.
35. Y.Moskowitz, E.Leibowitz, M.Ronen, E.Aviel. 1993. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 25:306–308.
36. T.Niwa, N.Murayama, H.Yamazaki. 2009. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome. Curr Drug Metab 10:700–712.
37. G.B.Oliveira, A.Fontes Ede, Jr, S.de Carvalho, J.B.da Silva, L.M.Fernandes, M.C.Oliveira,. 2014. Minocycline mitigates motor impairments and cortical neuronal loss induced by focal ischemia in rats chronically exposed to ethanol during adolescence. Brain Res 1561:23–34.
38. F.Regen, I.Heuser, I.Herzog, J.Hellmann-Regen. 2013. Striking Growth-inhibitory effects of minocycline on human prostate cancer cell lines. Urology 83:509.
39. S.Reijntjes, E.Gale, M.Maden. 2004. Generating gradients of retinoic acid in the chick embryo:Cyp26C1 expression and a comparative analysis of the Cyp26 enzymes. Dev Dyn 230:509–517.
40. G.Z.Reus, H.M.Abelaira, A.L.Maciel, M.A.Dos Santos, A.S.Carlessi, A.V.Steckert,. 2014. Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress. Metab Brain Dis 30:545–553.
41. J.Savitz, S.Preskorn, T.K.Teague, D.Drevets, W.Yates, W.Drevets. 2012. Minocycline and aspirin in the treatment of bipolar depression:a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial. BMJ Open 2:e000643.
42. K.D.Shearer, Y.D.Fragoso, M.Clagett-Dame, P.J.McCaffery. 2012a. Astrocytes as a regulated source of retinoic acid for the brain. Glia 60:1964–1976.
43. K.D.Shearer, P.N.Stooney, S.E.Nanescu, G.Helfer, P.Barrett, A.W.Ross,. 2012b. Photoperiodic expression of two RALDH enzymes and the regulation of cell proliferation by retinoic acid in the rat hypothalamus. J Neurochem 122:789–799.
44. L.F.Shi. 2007. Tetracycline-family antibiotics and pseudotumor cerebri. J Am Acad Audiol 18:453–454; author reply 454.
45. J.E.Thatcher, N.Isoherranen. 2009. The role of CYP26 enzymes in retinoic acid clearance. Expert Opin Drug Metab Toxicol 5:875–886.
46. Y.Tian, S.Guo, X.Wu, L.Ma, X.Zhao. 2015. Minocycline alleviates sevoflurane-induced cognitive impairment in aged rats. Cell Mol Neurobiol 35:585–594.
47. M.Wagner, B.Han, T.M.Jessell. 1992. Regional differences in retinoid release from embryonic neural tissue detected by an in vitro reporter assay. Development 116:55–66.
48. V.W.Yong, J.Wells, F.Giuliani, S.Casha, C.Power, L.M.Metz. 2004. The promise of minocycline in neurology. Lancet Neurol 3:744–751.
49. J.Yrjanheikki, T.Tikka, R.Keinanen, G.Goldsteins, P.H.Chan, J.Koistinaho. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496–13500.
50. X.J.Zhao, T.Ishizaki. 1999. A further interaction study of quinine with clinically important drugs by human liver microsomes:determinations of inhibition constant (Ki) and type of inhibition. Eur J Drug Metab Pharmacokinet 24:272–278.